日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Osimertinib with or without savolitinib as first-line treatment for MET-aberrant, EGFR-mutant NSCLC: randomized phase 2 trial (FLOWERS)

奥希替尼联合或不联合沙沃替尼作为MET异常、EGFR突变型非小细胞肺癌的一线治疗:随机2期试验(FLOWERS)

Li, Anna; Feng, Wei-Neng; Li, Juan; Xu, Bing-Fei; Zhao, Jun; Jia, Yun; Tang, Ke-Jing; Li, Yong-Sheng; Zhou, Cheng-Zhi; Fan, Yun; Xu, Chong-Rui; Sun, Yue-Li; Chen, Hua-Jun; Yan, Hong-Hong; Shi, Zong-Kun; Yang, Jin-Ji

PFOS Disrupts Oocyte Maturation and Early Embryonic Development via Ovarian FOXK1 O-GlcNAcylation in Mice.

PFOS 通过卵巢 FOXK1 O-GlcNAc 化干扰小鼠卵母细胞成熟和早期胚胎发育。

Han Shuwen, Yuan Qin, Wu Zhu, Fang Yaohui, Qian Hong, Zhu Jiale, Zhang Yuchen, Deng Ke, Su Liangliang, Xu Haibo, Shu Haotian, Gong Yiming, Xu Qiaoqiao, Du Guizhen, Wu Di, Fan Yun, Lu Chuncheng

Efficacy and safety of savolitinib in Chinese patients with locally advanced or metastatic MET exon 14-mutated non-small cell lung cancer: final results of a confirmatory Phase 3b study

savolitinib治疗局部晚期或转移性MET 14号外显子突变型非小细胞肺癌中国患者的疗效和安全性:一项确证性3b期研究的最终结果

Yu, Yongfeng; Guo, Qisen; Zhang, Yongchang; Fang, Jian; Zhong, Diansheng; Liu, Baogang; Pan, Pinhua; Lv, Dongqing; Wu, Lin; Zhao, Yanqiu; Li, Juan; Liu, Zhihua; Liu, Chunling; Su, Haichuan; Fan, Yun; Zhang, Tongmei; Liu, Anwen; Jin, Bo; Wang, Ye; Zhou, Jianying; Zhang, Zhihong; Ran, Fengming; Song, Xia; Shi, Michael M; Su, Weiguo; Lu, Shun

Calcium signaling regulates apoptosis-induced proliferation in Drosophila

钙信号调节果蝇凋亡诱导的增殖

Suthar, Komal Panchal; Hounsell, Caitlin; Fan, Yun; Bergmann, Andreas

Five-year outcomes of pembrolizumab versus chemotherapy in Chinese patients with non-small-cell lung cancer and programmed cell death ligand 1 tumor proportion score ≥1%: KEYNOTE-042 China study

帕博利珠单抗与化疗治疗中国非小细胞肺癌且程序性死亡配体1肿瘤比例评分≥1%患者的五年疗效:KEYNOTE-042中国研究

Wu, Yi-Long; Zhang, Li; Fan, Yun; Zhou, JianYing; Zhang, Li; Zhou, Qing; Li, Wei; Hu, ChengPing; Chen, GongYan; Zhang, Xin; Zhou, CaiCun; Arenas, Carmen González; Chen, Zhenghong; Yu, Wen Cheng; Mok, Tony S K

GlycA as an Effect Modifier of Protein-Mortality Associations: A Prospective Cohort Study

GlycA作为蛋白质-死亡率关联的效应调节因子:一项前瞻性队列研究

Wang, Xinru; Qiao, Ziyan; Tao, Chengzhe; Liao, Sijing; Li, Zhi; Xu, Qiaoqiao; Fan, Yun; Wang, Yufeng; Han, Yan; Dai, Xiuliang; Lu, Chuncheng

Association between adherence to a healthy lifestyle and firefighters' depression and posttraumatic stress disorder in Taiwan: A longitudinal, prospective cohort study

台湾消防员健康生活方式与抑郁症和创伤后应激障碍之间的关联:一项纵向前瞻性队列研究

Lan, Fan-Yun; Lin, Yen-Wei; Huang, Chen-Yu; Yu, Hsiao-Jou; Fernandez-Montero, Alejandro; Lin, Chih-Hao; Kales, Stefanos N

Is there a difference in catheter-related thrombosis between left- and right-sided arm ports and chest ports?

左侧手臂端口、右侧手臂端口和胸部端口在导管相关血栓形成方面是否存在差异?

Fan, Yun; Du, Huarong; Guan, Yuanyuan; Zhang, Aili; Jiang, Xiaolin

A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1/1b trial.

针对晚期实体瘤的 B7H3 靶向抗体药物偶联物:一项 1/1b 期试验

Ma Yuxiang, Yang Yunpeng, Huang Yan, Fang Wenfeng, Xue Jinhui, Meng Xiangjiao, Fan Yun, Fu Siqing, Wu Lin, Zheng Yulong, Liu Jian, Liu Zhihua, Zhuang Wu, Rosen Seth, Qu Song, Li Bihui, Li Mingjun, Zhao Yanqiu, Yang Shujun, Ji Yinghua, Sommerhalder David, Luo Suxia, Yang Kunyu, Li Jingao, Lv Dongqing, Zhang Peng, Zhao Yuanyuan, Hong Shaodong, Zhang Yang, Zhao Shen, Chin Steve, Zhang Xian, Lian Wei, Cai Jiaqiang, Xue Tongtong, Zhang Li, Zhao Hongyun

Sacituzumab tirumotecan versus docetaxel for previously treated EGFR-mutated advanced non-small cell lung cancer: multicentre, open label, randomised controlled trial

Sacituzumab tirumotecan 与多西他赛治疗既往接受过治疗的 EGFR 突变晚期非小细胞肺癌:一项多中心、开放标签、随机对照试验

Fang, Wenfeng; Li, Xingya; Wang, Qiming; Meng, Xiangjiao; Zheng, Wei; Sun, Longhua; Yao, Wenxiu; Zhuang, Wu; Fan, Yun; Zhuo, Minglei; Luo, Yongzhong; Zhang, Zhiye; Song, Xia; Yang, Runxiang; Yang, Jiacheng; Jin, Xiaoping; Diao, Yina; Ge, Junyou; Zhang, Li